Standard Biotools (LAB) Free Cash Flow Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 9.23% |
| 10 | Standard Biotools | 251.45 Mn | -225.27 Mn | 10.54 Mn | -1.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.58% |
| Mar 31, 2026 | -70.32% |
| Dec 31, 2025 | 54.27% |
| Sep 30, 2025 | 5.04% |
| Jun 30, 2025 | 20.06% |
| Mar 31, 2025 | -29.01% |
| Dec 31, 2024 | -179.35% |
| Sep 30, 2024 | 12.99% |
| Jun 30, 2024 | 0.34% |
| Mar 31, 2024 | -47.22% |
| Dec 31, 2023 | 7.83% |
| Sep 30, 2023 | -35.62% |
| Jun 30, 2023 | -43.63% |
| Mar 31, 2023 | -21.26% |
| Dec 31, 2022 | -49.06% |
| Sep 30, 2022 | -63.74% |
| Jun 30, 2022 | -78.56% |
| Mar 31, 2022 | 6.90% |
| Dec 31, 2021 | 8.75% |
| Sep 30, 2021 | -127.01% |